Platelet-to-lymphocyte ratio is not a predictor of clinically significant prostate cancer at the prostate biopsy: A large cohort study

Previous studies have reported conflicting results on the predictive role of the platelet-to-lymphocyte ratio (PLR) in detecting clinically significant prostate cancer (CSPCa) at the time of prostate biopsies. We explored the predictive value of pre-biopsy PLRs for CSPCa using our large-cohort datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeong Woo, Jeong, Hyeon, Son, Hwancheol, Cho, Min Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270979/
https://www.ncbi.nlm.nih.gov/pubmed/34244550
http://dx.doi.org/10.1038/s41598-021-93637-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270979/
https://www.ncbi.nlm.nih.gov/pubmed/34244550
http://dx.doi.org/10.1038/s41598-021-93637-3

Ejemplares similares